D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 54 Citations 8,241 144 World Ranking 2898 National Ranking 92

Overview

What is she best known for?

The fields of study she is best known for:

  • Bacteria
  • Internal medicine
  • Antibiotics

Teresa Peláez mostly deals with Microbiology, Internal medicine, Amphotericin B, Aspergillus fumigatus and Aspergillus. Her is doing research in Broth microdilution, Drug resistance, Voriconazole, Posaconazole and Clostridium difficile, both of which are found in Microbiology. The various areas that she examines in her Internal medicine study include Endocrinology, Fungemia and Surgery.

In the field of Amphotericin B, her study on Flucytosine overlaps with subjects such as Wild type. Teresa Peláez has included themes like Acquired resistance and Aspergillosis in her Aspergillus fumigatus study. Her studies in Aspergillus integrate themes in fields like Mucorales, Scedosporium, Fusarium and Isavuconazonium.

Her most cited work include:

  • Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease (334 citations)
  • Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. (239 citations)
  • Reassessment of Clostridium difficile Susceptibility to Metronidazole and Vancomycin (222 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Microbiology, Aspergillus fumigatus, Internal medicine, Aspergillosis and Voriconazole. Her study in Amphotericin B, Clostridium difficile, Posaconazole, Itraconazole and Etest falls within the category of Microbiology. Her Aspergillus fumigatus research includes elements of Genetics, Azole, Genotype and Virulence.

Teresa Peláez has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Surgery. Her Aspergillosis research incorporates elements of Mycosis, Outbreak, Intensive care unit and Aspergillus. Her Voriconazole research integrates issues from Fluconazole and Drug resistance.

She most often published in these fields:

  • Microbiology (75.00%)
  • Aspergillus fumigatus (25.61%)
  • Internal medicine (18.90%)

What were the highlights of her more recent work (between 2014-2021)?

  • Microbiology (75.00%)
  • Aspergillus fumigatus (25.61%)
  • Amphotericin B (20.12%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Microbiology, Aspergillus fumigatus, Amphotericin B, Azole and Aspergillosis. Her Microbiology study frequently draws connections between related disciplines such as Genotype. Her research integrates issues of Galleria mellonella, Virulence, Genotyping, Etest and Histopathology in her study of Aspergillus fumigatus.

The concepts of her Amphotericin B study are interwoven with issues in Malassezia pachydermatis, Fluconazole, Echinocandin and Yeast. Her research in Azole intersects with topics in Mutation, Gene and Candida tropicalis. Her work carried out in the field of Metronidazole brings together such families of science as Clindamycin, Erythromycin and Clostridium difficile.

Between 2014 and 2021, her most popular works were:

  • International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method. (71 citations)
  • Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales (54 citations)
  • Multicenter study of method-dependent epidemiological cutoff values for detection of resistance in candida spp. and aspergillus spp. to amphotericin B and echinocandins for the etest agar diffusion method (50 citations)

In her most recent research, the most cited papers focused on:

  • Bacteria
  • Internal medicine
  • Antibiotics

Her primary areas of study are Microbiology, Aspergillus fumigatus, Amphotericin B, Posaconazole and Aspergillus. When carried out as part of a general Microbiology research project, her work on Candida albicans, Voriconazole and Itraconazole is frequently linked to work in Antiinfective agent, therefore connecting diverse disciplines of study. Teresa Peláez interconnects Anidulafungin, Caspofungin and Etest in the investigation of issues within Candida albicans.

Her biological study deals with issues like Aspergillosis, which deal with fields such as Aspergillus terreus. As part of the same scientific family, Teresa Peláez usually focuses on Aspergillus fumigatus, concentrating on Azole and intersecting with Pulmonary disease and Virulence. Her Mucorales research is multidisciplinary, incorporating elements of Broth microdilution and Fusarium.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease

Patricia Muñoz;Emilio Bouza;Manuel Cuenca-Estrella;Jose María Eiros.
Clinical Infectious Diseases (2005)

526 Citations

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.

J. Guinea;M. Torres-Narbona;P. Gijón;P. Muñoz.
Clinical Microbiology and Infection (2010)

407 Citations

Reassessment of Clostridium difficile Susceptibility to Metronidazole and Vancomycin

T. Peláez;L. Alcalá;R. Alonso;M. Rodríguez-Créixems.
Antimicrobial Agents and Chemotherapy (2002)

341 Citations

In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species

Jesús Guinea;Teresa Peláez;Sandra Recio;Marta Torres-Narbona.
Antimicrobial Agents and Chemotherapy (2008)

257 Citations

Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)

A. Alastruey-Izquierdo;E. Mellado;T. Peláez;J. Pemán.
Antimicrobial Agents and Chemotherapy (2013)

247 Citations

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

A. Espinel-Ingroff;D. J. Diekema;A. Fothergill;Elizabeth Johnson.
Journal of Clinical Microbiology (2010)

233 Citations

Metronidazole Resistance in Clostridium difficile Is Heterogeneous

T. Peláez;E. Cercenado;L. Alcalá;M. Marín.
Journal of Clinical Microbiology (2008)

215 Citations

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

A. Espinel-Ingroff;M. C. Arendrup;M. A. Pfaller;L. X. Bonfietti.
Antimicrobial Agents and Chemotherapy (2013)

214 Citations

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

A. Espinel-Ingroff;M. Cuenca-Estrella;A. Fothergill;J. Fuller.
Antimicrobial Agents and Chemotherapy (2011)

194 Citations

Group B streptococcus bacteremia in nonpregnant adults

Patricia Muñoz;Alvaro Llancaqueo;Marta Rodríguez-Créixems;Teresa Peláez.
JAMA Internal Medicine (1997)

180 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Teresa Peláez

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 100

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 98

Emilio Bouza

Emilio Bouza

Hospital General Universitario Gregorio Marañón

Publications: 96

David W. Denning

David W. Denning

University of Manchester

Publications: 71

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 63

Jesús Guinea

Jesús Guinea

Hospital General Universitario Gregorio Marañón

Publications: 61

Ferry Hagen

Ferry Hagen

Utrecht University

Publications: 57

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 57

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 53

Teun Boekhout

Teun Boekhout

University of Amsterdam

Publications: 46

Eric Dannaoui

Eric Dannaoui

Université Paris Cité

Publications: 43

Ed J. Kuijper

Ed J. Kuijper

Leiden University Medical Center

Publications: 42

Joseph Meletiadis

Joseph Meletiadis

National and Kapodistrian University of Athens

Publications: 39

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 38

Anuradha Chowdhary

Anuradha Chowdhary

University of Delhi

Publications: 38

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 37

Trending Scientists

Jussara M. Almeida

Jussara M. Almeida

Universidade Federal de Minas Gerais

Paul Yang

Paul Yang

Princeton University

François Baccelli

François Baccelli

The University of Texas at Austin

Janet Arey

Janet Arey

University of California, Riverside

Edwin N. Frankel

Edwin N. Frankel

University of California, Davis

Hong Xia

Hong Xia

Jilin University

Lei Ge

Lei Ge

China University of Petroleum, Beijing

Laszlo S. Toth

Laszlo S. Toth

University of Lorraine

Vinay Gupta

Vinay Gupta

University of Delhi

Stephen W. White

Stephen W. White

St. Jude Children's Research Hospital

Nikolai Østgaard

Nikolai Østgaard

University of Bergen

Kathrin Koch

Kathrin Koch

Technical University of Munich

Sarah J. Augood

Sarah J. Augood

Harvard University

William Mandy

William Mandy

University College London

Carol S. Fullerton

Carol S. Fullerton

Uniformed Services University of the Health Sciences

Thomas P. Robitaille

Thomas P. Robitaille

Max Planck Society

Something went wrong. Please try again later.